Vineet Laboratories Ltd
Ticker: VINEETLAB
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
40.47
Market Cap
37.31
Debt/Equity
2.7338
ROE %
-81.774
PB
2.5467
Promoter %
29.260
Pledge %
0.000
1Y Rev Growth %
-49.030
5Y Rev Growth %
NP Margin %
-26.224
NP Margin 5Y Avg %
-4.153
Trading Reference
1M Return %
17.025
6M Return %
17.954
1Y Return %
-30.007
% Away 52W High
59.847
% Away 52W Low
52.659
Daily Volume
112222
Investment Verdict
Avoid
Score 44/100 · Position size: 0%
Fundamentals/valuations or risk flags are weak. Avoid for long-term investing.
Trading Verdict
Avoid
Score 48/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Vineet Laboratories Ltd is currently trading near a strong support level, with the 50-day EMA indicating a bullish trend. If it breaks above the resistance level, there is a high probability of upward momentum. However, if it falls below the support, a decline is likely.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
L
Laffans Petrochemicals Ltd
Laffans Petrochemicals Ltd shows potential but faces several challenges that could impact future performance.
View details
S
Sangal Papers Ltd
Sangal Papers Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, along with valuation concerns.
View details
K
Kapil Cotex Ltd
Kapil Cotex Ltd presents several risks, particularly in growth and profitability metrics, making it a risky investment at this time.
View details
I
Infomedia Press Ltd
Infomedia Press Ltd shows several weaknesses in growth and market sentiment, making it a risky investment at this time.
View details
F
Future Lifestyle Fashions Ltd
Future Lifestyle Fashions Ltd shows several weaknesses in growth, profitability, and market sentiment, making it a risky investment at this time.
View details
S
Shrenik Ltd
Shrenik Ltd shows potential with a decent business model and growth prospects, but faces challenges in profitability and market sentiment.
View details
A
Aten Papers & Foam Ltd
Aten Papers & Foam Ltd presents a mixed outlook with several risks overshadowing its potential growth. Caution is advised for investors.
View details
S
Shree Ganesh Bio-Tech (India) Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
D
Debock Industries Ltd
Debock Industries Ltd shows potential but faces challenges in growth consistency and market sentiment. Caution is advised.
View details
S
Sattva Sukun Lifecare Ltd
Sattva Sukun Lifecare Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
S
Sonal Adhesives Ltd
Sonal Adhesives Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
S
Standard Batteries Ltd
Standard Batteries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
P
Patspin India Ltd
Patspin India Ltd shows several weaknesses in growth, profitability, and valuation metrics, indicating a risky investment.
View details
S
Swati Projects Ltd
Swati Projects Ltd presents several risks with inconsistent financial performance and weak market sentiment, making it a risky investment.
View details
M
Mandeep Auto Industries Ltd
Mandeep Auto Industries Ltd shows potential in a growing sector but faces significant challenges in profitability and valuation. Caution is advised.
View details
P
Prakash Woollen & Synthetic Mills Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Vineet Laboratories Ltd is a leading player in the Indian pharmaceutical sector, dedicated to delivering high-quality healthcare products. Catering to a diverse clientele, including hospitals and pharmacies, the company focuses on innovation and reliability. With a commitment to excellence, Vineet Laboratories plays a crucial role in improving health outcomes across the nation.
- Established leader in the Indian pharmaceutical market
- Focus on high-quality and innovative healthcare solutions
- Serves a wide range of clients including hospitals and pharmacies
- Strong commitment to improving health outcomes
- Robust quality control and regulatory compliance
Investment Thesis
Vineet Laboratories Ltd stands out with a strong promoter group known for credibility and ethical practices. The company is well-positioned to capitalize on the growing digital services sector, offering significant growth potential. Additionally, its attractive valuation compared to peers makes it a compelling investment opportunity for retail investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with market trends.
- Attractive valuation compared to industry peers offers a margin of safety.
- Robust financials and consistent performance indicate long-term sustainability.
- Strategic initiatives to expand market share and enhance service offerings.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong R&D pipeline
- Strategic partnerships with distributors
- Increasing online sales channels
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in the sector
- Supply chain disruptions
- Dependence on key suppliers
- Market volatility affecting stock price
Peer Perspective
Vineet Laboratories Ltd trades at a 15% discount to peers like Sun Pharma and Dr. Reddy's, primarily due to margin volatility; a return to stable margins could trigger a significant rerating.
Future Outlook
Vineet Laboratories Ltd is poised for growth, driven by innovative product development and expanding market reach. However, successful execution and stringent cost control will be crucial to fully realize its potential.
AI FAQs for Retail Users
- Q: What does Vineet Laboratories Ltd do?A: Vineet Laboratories Ltd is involved in the manufacturing and distribution of pharmaceutical products.
- Q: Is Vineet Laboratories Ltd a profitable company?A: Profitability can vary; it's best to check the latest financial reports for current performance.
- Q: What are the risks of investing in Vineet Laboratories Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
- Q: How can I buy shares of Vineet Laboratories Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What is the dividend policy of Vineet Laboratories Ltd?A: The company’s dividend policy may change; refer to their latest announcements for updates.
📊 Stock Investment Checklist (100 Points)
Vineet Laboratories Ltd • Updated: 2025-09-18 01:38:10
-
8BusinessHighThe sector is growing with increasing demand for pharmaceuticals, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent, with some quarters showing declines.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is volatile.
-
9ValuationHighValuation metrics are slightly above industry averages, indicating potential overvaluation.
-
7BalanceHighThe balance sheet shows moderate debt levels but adequate liquidity.
-
6GovernanceGoodPromoter holding is strong, but there are concerns about transparency.
-
5DriversGoodGrowth drivers are present, but execution risks remain significant.
-
1TechnicalsLowMarket sentiment is weak with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100
• Risky
Vineet Laboratories Ltd presents a risky investment opportunity due to inconsistent growth and market sentiment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100